depression and tirzepatide Psychiatric Safety of Tirzepatide: 3 Surprising Findings from a Landmark Post Hoc Analysis of SURMOUNT New weight-loss drugs linked to

The SELECT trial, published in The Lancet (October 22, 2025), provides a landmark analysis confirming that the cardioprotective benefits of semaglutide extend beyond weight loss alone. The SELECT Trial: Study Overview The SELECT trial (NCT03574597) enrolled 17,604 participants aged 45 years and above across 41 countries and 804 sites

Muscle and Fat (Insulin Sensitivity): GLP-1 RAs enhance glucose uptake in muscle and adipose tissue via the PI3K/Akt pathway, improving overall insulin sensitivity (Zheng et al., 2024)

And by injection day, it feels like the tirzepatide weight loss timeline has stalled completely

Dpc = absorbance of the positive control

By entering a few key details, you'll receive an accurate dose conversion that aligns with best practices in animal care

In one study among 41 children with CVS, 39% of children reported resolution of symptoms either immediately or within weeks from diagnosis